• Journal of the Korean Society for Nondestructive Testing
• /
• v.25 no.4
• /
• pp.268-273
• /
• 2005

The spirometer is a medical device that measures the instantaneous velocity of the respiratory gas flow capacity. It is used for testing the condition of the lung and patient monitoring. It measures the absolute capacity difference that includes the flow capacity signal. In this paper, by using an ultrasound sensor that reduce+ the error caused by the inertia and pressure it has improved the transmission and receiving signal. This has enabled patients with weak respiratory to use the spirometer. Also, by using the ARM 920T Processor, a precise and prompt detection system was implemented.

• Proceedings of the Korean Institute of Information and Commucation Sciences Conference
• /
• v.9 no.2
• /
• pp.417-420
• /
• 2005

The spirometer is a medical device that measures the instantaneous velocity of the respiratory gas flow capacity. It is used for testing the condition of the lung and patient monitoring. It measures the absolute capacity difference that includes the flow capacity signal. In this paper, by using an ultrasound sensor that reduce the error caused by the inertia and pressure it has improved the transmission and receiving signal. This has enabled patients with weal respiratory to use the spirometer. Also, by using the embedded hardware system, a precise and prompt detection system was implemented.

• 대한예방의학회:학술대회논문집
• /
• 2001.10a
• /
• pp.446-447
• /
• 2001

• Physical Therapy Korea
• /
• v.8 no.4
• /
• pp.71-80
• /
• 2001

근위축성 측색 경화증 (amyotrophic lateral sclerosis: ALS) 환자에게 있어 호흡기능장애는 죽음에 이르게 하는 주요 원인 중 하나이다. 본 연구는 근위축성 측색 경화증이 있으며 호흡기능이 약화되어 있는 51세의 여성 환자를 대상으로 호흡운동 치료를 시행한 후 폐기능(pulmonary function)이 증진되었는지를 알아보고자 실시하였다. 연구 대상자는 6주간의 호흡운동 치료 프로그램에 참여하였다. 호흡운동 치료 프로그램은 횡경막 호흡(diaphragmatic breathing), 복부근육강화(abdominal mu scles strengthening), 지갑입술 호흡(pursed lip breathing), 그리고 동기 유발성 흡기폐활량계(incentive spirometer)를 이용한 흡기운동 등으로 구성되었다. 폐기능 검사는 이동식 호흡측정기(spirometer: MICROSPIROHI-198)를 이용해서 시행하였다. 또한 하지 에르고미터(cycle- ergometer)를 이용해 운동 시간을 측정함으로써 폐기능의 증진 여부를 알아보았다. 연구 대상자는 6주간의 호흡운동 치료 기간 동안 노력성 폐활량(forced vital capacity: FVC)과 정상 예측치에 대한 노력성 폐활량의 비율(percentage of the predicted forced vital capacity: %FVC), 그리고 하지 에르고미터의 운동 시간에 있어 현저한 증가를 보였다. 그러나 노력성 폐활량에 대한 1초간 노력성 폐활량 비(FEV1/ FVC)에 있어서는 약간의 감소를 보였다. 근위축성 측색 경화증 환자에게 6주간의 호흡운동 치료를 실시한 결과, 폐기능의 증진에 효과적임을 알 수 있었으며, 앞으로 더 많은 연구 대상자에게 그 효과를 알아보는 연구가 필요할 것이다.

• Journal of the Korean Society of Physical Medicine
• /
• v.8 no.1
• /
• pp.59-69
• /
• 2013

연구목적: 본 연구는 만성 뇌졸중 환자를 대상으로 흡기근 저항훈련이 횡격막 두께와 폐기능 및 흉곽 확장에 미치는 효과를 알아보고자 수행하였다. 연구방법: 연구 대상자는 총 29명(남자 17명, 여자 12명)으로 흡기근 저항훈련군(15명)과 대조군(14명)으로 분류하였다. 모든 대상자는 6개월 이상된 만성 뇌졸중 환자로 일반적인 신경발달치료를 받고 있으며, 같은 기간 동안 흡기근 저항훈련군에 역치부하 흡기근육 단련기(threshold IMT device)를 제공하고 주 3회${\times}$1회 20분씩 6주간 시행하였다. 마비측과 비마비측 횡격막 두께측정을 위해 초음파의 7.5MHz linear probe를 사용하여 최대 흡기시(Tdi.con)와 휴식시(Tdi.rel)의 두께를 측정하고 수축률(TR)을 계산하였다. 또한 폐 활량계를 사용하여 노력성 폐활량을 측정하였으며, 줄자를 사용하여 흉곽 확장을 측정하였다. 연구결과: 6주간 중재 후 흡기근 저항훈련군에서 최대흡기시 횡격막 두께(Tdi.con)와 수축률(TR)은 유의한 증가를 보였다(p<.05). 1초간 노력성 호기량 ($FEV_1$)과 최대 호기 속도(PEF)도 유의한 증가를 보였으나(p<.05), 노력성 폐활량(FVC)과 1초간 노력성 호기량의 노력성 폐활량에 대한 비($FEV_1$/FVC), 흉곽 확장은 유의한 증가는 보이지 않았다(p>.05). 결론: 본 연구는 만성뇌졸중 환자를 대상으로 흡기근 저항훈련의 적용이 횡격막의 수축력과 폐기능 및 흉곽 확장력을 향상시켜 호흡근의 협응력을 증가시키고, 비활동성으로 인해 감소된 운동내성을 증가하게 함으로써 향후 재활에서 만성 뇌졸중 환자에게 2차적인 기능향상에 도움을 줄수 있을 것으로 보여진다.

• Tuberculosis and Respiratory Diseases
• /
• v.43 no.4
• /
• pp.558-570
• /
• 1996

Background : The detection of Collapsible airways has important therapeutic implications in chronic airway disease and bronchial asthma. The distinction of a purely collapsible airways disease from that of asthma is important because the treatment of the dormer may include the use of pursed lip breathing or nasal positive pressure ventilation whereas in the latter, pharmacologic approaches are used. One form of irreversible airflow limitation is collapsible airways, which has been shown to be a Component of asthma or to emphysema, it can be assessed by the volume difference between what exits the lung as determined by a spirometer and the volume compressed as measured by the plethysmography. Method : To investigate whether volume difference between slow and forced vital Capacity(SVC-FVC) by spirometry may be used as a surrogate index of airway collapse, we examined pulmonary function parameters before and after bronchodilator agent inhalation by spirometry and body plethysmography in 20 cases of patients with evidence of airflow limitation(chronic obstructive pulmonary disease 12 cases, stable bronchial asthma 7 cases, combined chronic obstructive pulmonary disease with asthma 1 case) and 20 cases of normal subjects without evidence of airflow limitation referred to the Pusan National University Hospital pulmonary function laboratory from January 1995 to July 1995 prospectively. Results : 1) Average and standard deviation of age, height, weight of patients with airflow limitation was $58.3{\pm}7.24$(yr), $166{\pm}8.0$(cm), $59.0{\pm}9.9$(kg) and those of normal subjects was $56.3{\pm}12.47$(yr), $165.9{\pm}6.9$(cm), $64.4{\pm}10.4$(kg), respectively. The differences of physical characteristics of both group were not significant statistically and male to female ratio was 14:6 in both groups. 2) The difference between slow vital capacity and forced vital capacity was $395{\pm}317ml$ in patients group and $154{\pm}176ml$ in normal group and there was statistically significance between two groups(p<0.05). Sensitivity and specificity were most higher when the cut-off value was 208ml. 3) After bronchodilator inhalation, reversible airway obstructions were shown in 16 cases of patients group, 7 cases of control group(p<0.05) by spirometry or body plethysmography d the differences of slow vital capacity and forced vital capacity in bronchodilator response group and nonresponse group were $300.4{\pm}306ml$, $144.7{\pm}180ml$ and this difference was statistically significant. 4) The difference between slow vital capacity and forced vital capacity before bronchodilator inhalation was correlated with airway resistance before bronchodilator(r=0.307 p=0.05), and the difference between slow vital capacity and forced vital capacity after bronchodilator was correlated with difference between slow vital capacity and forced vital capacity(r=0.559 p=0.0002), thoracic gas volume(r=0.488 p=0.002) before bronchodilator and airway resistance(r=0.583 p=0.0001), thoracic gas volume(r=0.375 p=0.0170) after bronchodilator, respectively. 5) The difference between slow vital capacity and forced vital capacity in smokers and nonsmokers was $257.5{\pm}303ml$, $277.5{\pm}276ml$, respectively and this difference did not reach statistical significance(p>0.05). Conclusion : The difference between slow vital capacity and forced vital capacity by spirometry may be useful for the detection of collapsible airway and may help decision making of therapeutic plans.

• Journal of the Korean Society of Radiology
• /
• v.17 no.5
• /
• pp.767-773
• /
• 2023

To In this study, we sought to evaluate related factors affecting lung volume and their significance in pulmonary function and ventilation disorders. As experimental subjects, 206 normal adult men and women who underwent a low-dose chest CT scan and a spirometry test were selected at the same time. The experimental method was to measure lung volume using lung CT images obtained through a low-dose chest CT scan using deep learning-based AVIEW. Measurements were made using the LCS automatic diagnosis program. In addition, the results of measuring lung function were obtained using a spirometer, and gender and BMI were selected as related factors that affect lung volume, and significance was evaluated through an independent sample T-test with lung volume. As a result of the experiment, it was confirmed that in evaluating lung volume according to gender, all lung volumes of men were larger than all lung volumes of women. he result of an independent samples T-test using the respective average values for gender and lung volume showed that all lung volumes were larger in men than in women, which was significant (p<0.001). And in the evaluation of lung volume according to BMI index, it was confirmed that all lung volumes of adults with a BMI index of 24 or higher were larger than all lung volumes of adults with a BMI index of less than 24. However, the independent samples T-test using the respective average values for BMI index and lung volume did not show a significant result that all lung volumes were larger in BMI index 24 or higher than in BMI index less than 24 (p<0.055). In the evaluation of lung volume according to the presence or absence of pulmonary ventilation impairment, it was confirmed that all lung volumes of adults with normal pulmonary function ventilation were larger than all lung volumes of adults with pulmonary ventilation impairment. And as a result of the independent sample T-test using the respective average values for the presence or absence of pulmonary ventilation disorder and lung volume, the result was significant that all lung volumes were larger in adults with normal pulmonary function ventilation than in adults with pulmonary function ventilation disorder (p <0.001). Lung volume and spirometry test results are the most important indicators in evaluating lung health, and using these two indicators together to evaluate lung function is the most accurate evaluation method. Therefore, it is expected that this study will be used as basic data by presenting the average lung volume for adults with normal ventilation and adults with impaired lung function and ventilation in similar future studies on lung volume and vital capacity testing.

• Journal of Sensor Science and Technology
• /
• v.11 no.3
• /
• pp.125-131
• /
• 2002

Respiratory air flow rate is necessarily measured for the pulmonary function evaluation. The currently used devices are exposed to the problems of measurement reliability and cross-patient infection. The present study introduced a new technique which converted the bidirectional air flow rate into averaged dynamic pressure based on the famous Bernoulli's energy conservation principle. Single use plastic sensing element was assembled within the flow tube(mouth piece) made of paper, which was named "functional single use flow tube". Experiment demonstrated only ${\pm}1.5%$ relative error in the standard 3L volume measurement procedure well within the error limit suggested by the American Thoracic Society(ATS). Disposable use design completely eliminated cross-patient infection. The present device is best useful and safe for clinical respiratory air flow measurement such as spirometry.

• Proceedings of the KIEE Conference
• /
• 2015.07a
• /
• pp.1429-1430
• /
• 2015

The present study developed an air flow generator system with standard syringes usually adapted for spirometer calibration. It consisted of servo-motor, driver, linear robot, and controller operating as a whole integrated system capable of generating air flows at different speeds on two identical 3L syringes. Experiments demonstrated high accuracy in both flow and volume generation as required such that relative errors were approximately 2.1% and 0.5%, respectively.

• Proceedings of the KOSOMBE Conference
• /
• v.1995 no.05
• /
• pp.64-67
• /
• 1995

전산화폐활량계를 국산화하기 위하여 호흡기류 계측시스템을 개발하였다. 호흡기류를 측정하는 방법으로 Pneumotachography를 적용하였다. 자체 Pneumotachometer를 설계, 제작하였고, 증폭기와 필터를 통하여 0 - 5 V 범위의 기류신호가 출력되도록 하였다. 온도보정을 위하여 기류의 온도를 K-type 열전쌍으로 연속측정하여 보정신호를 역시 0 - 5 V 범위로 제공하도록 제작하였으며 따라서 온도에 따른 측정오차를 근본적으로 제거하였다. 피검자의 감염 가능성을 최소화하기 위하여 환기기구를 사용하였으며 전력소모가 적고 미세균의 제거가 가능하다. 본 시스템의 특성 측정 결과 충분히 우수한 정특성과 동특성을 얻었으며 현재 호흡기류를 정량분석하는 S/W-시스템을 개발중이다.